Dr. Thomas Lodise is an associate professor at Albany College of Pharmacy and Health
Sciences, Albany, New York. Dr. Lodise, a 1999 summa cum laude doctor of pharmacy graduate
of Temple University School of Pharmacy, joined the faculty at Albany College of Pharmacy in
August 2002. Prior to Albany College of Pharmacy, he completed the APhA-ASHP–accredited
Pharmacy Practice Residency at Thomas Jefferson University Hospital, Philadelphia,
Pennsylvania in 2000 and the Infectious Diseases Pharmacotherapy and Outcomes Fellowship at
Wayne State University, Detroit, Michigan in 2002. Integrating his dual interests in research and
patient care, his current research focuses on the epidemiology and outcomes of bacterial
infections, and his work explores the antibiotic exposure-response relationship among patients.
His specific objectives are 3-fold: develop patient care strategies and antibiotic regimens that
improve outcomes, reduce the likelihood of toxicity, and minimize the emergence of antibiotic
resistance. Dr. Lodise is currently implementing epidemiological and outcomes research
proposals at both the Albany Medical Center and Stratton VA Medical Center, Albany, New York.
He also collaborates extensively with the Ordway Research Institute, Albany, New York. He has
published over 40 peer-reviewed articles in reputable scientific journals, including Clinical
Infectious Diseases, Antimicrobial Agents and Chemotherapy, Chest, and Journal of Antimicrobial
Chemotherapy. He has also secured over $1 million in grant funding. Dr. Lodise coordinates the
antibiotic monitoring service at the Stratton VA Medical Center. He is a member of the Antibiotic
Subcommittee at the Albany Medical Center Hospital and is a visiting professor at Ordway
Research Institute. He is also enrolled in the doctor of philosophy program in epidemiology at the
State University of New York School of Public Health, Albany, New York.